Fig. 3From: A physiologically based pharmacokinetic (PBPK) model to describe organ distribution of 68Ga-DOTATATE in patients without neuroendocrine tumorsObserved peptide uptake (µg/l) for spleen (a), liver (b) and thyroid (c) versus administered DOTATATE amount (µg) for 41 patients without neuroendocrine tumors, where a correlation was observed that higher administered peptide amounts seem to result in increased uptake in these organsBack to article page